The securities of Suda Pharmaceuticals Ltd (‘SUD’) will be placed in trading halt at the request of SUD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Tuesday, 22 June 2021 or when the announcement is released to the market.
For more information, download the attached PDF.
Download this document
